首页> 外文OA文献 >Should Dose-dense Paclitaxel in Combination With Carboplatin Be the New Standard for Treatment for Suboptimally Debulked Patients or Patients Treated With Neoadjuvant Chemotherapy?

【2h】

Should Dose-dense Paclitaxel in Combination With Carboplatin Be the New Standard for Treatment for Suboptimally Debulked Patients or Patients Treated With Neoadjuvant Chemotherapy?

机译：剂量密集型紫杉醇联合卡铂是否应成为亚最佳减重患者或新辅助化疗患者的新治疗标准？

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Huang Marilyn; Coleman Robert L.;
展开▼
作者单位

展开▼
年度 2012
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Phase III study of valspodar (PSC 833) combined with paclitaxel and carboplatin compared with paclitaxel and carboplatin alone in patients with stage IV or suboptimally debulked stage III epithelial ovarian cancer or primary peritoneal cancer. [J] . Lhomme C, Joly F, Walker JL, Journal of Clinical Oncology . 2008,第16期

机译：IV期或亚减量最理想的III期上皮性卵巢癌或原发性腹膜癌患者中，valspodar（PSC 833）与紫杉醇和卡铂联合单独使用紫杉醇和卡铂的III期研究。
2. Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naive advanced non-small cell lung cancer. [J] . Langer CJ, OByrne KJ, Socinski MA, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2008,第6期

机译：III期试验比较了紫杉醇poliglumex（CT-2103，PPX）联合卡铂与标准紫杉醇和卡铂在未接受化疗的PS 2初发性晚期非小细胞肺癌患者中的治疗。
3. Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naive advanced non-small cell lung cancer. [J] . Langer CJ, OByrne KJ, Socinski MA, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2008,第6期

机译：III期试验比较了紫杉醇poliglumex（CT-2103，PPX）联合卡铂与标准紫杉醇和卡铂在未接受化疗的PS 2初发性晚期非小细胞肺癌患者中的治疗。
4. Extraction of Radiomic Features from Breast DCE-MRI Responds to Pathological Changes in Patients During Neoadjuvant Chemotherapy Treatment [C] . Priscilla Dinkar Moyya, Mythili Asaithambi, Anandh Kilpattu Ramaniharan IEEE International Conference on Imaging Systems and Techniques . 2019

机译：乳腺癌DCE-MRI放射特征的提取对新辅助化疗期间患者的病理变化做出响应
5. Posttraumatic stress disorder and sub-syndromal trauma symptoms in cancer patients treated with autologous hematopoietic stem cell transplant and standard dose chemotherapy. [D] . Gourvitz, Ross L. 2008

机译：自体造血干细胞移植和标准剂量化疗治疗的癌症患者的创伤后应激障碍和综合征下创伤症状。
6. Addition of carboplatin-gemcitabine as second-line neoadjuvant chemotherapy in non-responsive locally advanced breast cancer patients to standard neoadjuvant chemotherapy and evaluation of factors affecting response: a randomized controlled trial [O] . Dena Firouzabadi, Amirreza Dehghanian, Alireza Rezvani, 2021

机译：添加Carboplatin-Gemcitabine作为二线Neoadjuvant化疗非响应局部晚期乳腺癌患者标准Neoadjuvant化疗和影响反应的因素评估：随机对照试验
7. Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancer [O] . Langer, C. J., O'Byrne, Kenneth J., Socinski, M. A., 2008

机译：III期试验比较紫杉醇poliglumex（CT-2103，PPX）联合卡铂与标准紫杉醇和卡铂治疗未曾化疗的PS 2晚期非小细胞肺癌

Should Dose-dense Paclitaxel in Combination With Carboplatin Be the New Standard for Treatment for Suboptimally Debulked Patients or Patients Treated With Neoadjuvant Chemotherapy?

著录项

引文网络

相似文献

相关主题

期刊订阅